Botensilimab,Balstilimab
Agenus
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
late breaking presentation of phase 1 study results for bot-bal icpi by dr. andrea bullock in heavily pretreated patients with mcrc , majority low tmb .
followed by excellent discussion by dr. guillemot argilles #wcgi2023 
Heme/Onc Fellow @ClevelandClin @ccfhemonc. Via @AHNIMres and @aiims_newdelhi. Interests #GIOncology  #CancerResearch. Also books, cycling and movies